ELISA validation was performed on 4 prospective urine biomarkers; of these IL-1α, IL-1ra, and IL-8 were validated to be significantly elevated in BC, with urine IL-8 demonstrating the best ability to distinguish more advanced stages and grades of BC from the less advanced stages and grades of BC. This evidence concerns the gene CXCL8 and breast cancer.